Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (HK:2196)
HKEX:2196
Shanghai Fosun Pharmaceutical (Group) Co (2196) Stock Price & Analysis
1 Followers
2196 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$11.32 - HK$21.10
Previous CloseHK$12.9
Volume3.15M
Average Volume (3M)5.47M
Market Cap
HK$59.76B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)13.0
Beta0.86
Next Earnings
Aug 28, 2024EPS Estimate
HK$0.3Last Dividend Ex-Date
Jul 26, 2024Dividend Yield3.49%
Share Statistics
EPS (TTM)1.00
Shares Outstanding551,940,500
10 Day Avg. Volume10,549,000
30 Day Avg. Volume5,472,636
Standard Deviation0.12
R-Squared0.16
Alpha0.00808
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Shanghai Fosun Pharmaceutical (Group) Co News
PremiumCompany Announcements
Fosun Pharma Announces New Drug Acceptance
PremiumCompany Announcements
Fosun Pharma’s New Drug Application Accepted
PremiumCompany Announcements
Fosun Pharma Announces Corporate Governance Update
PremiumCompany Announcements
Fosun Pharma Announces Merger Delay
PremiumCompany Announcements
Fosun Pharma Advances Towards Henlius Privatization
PremiumCompany Announcements
Fosun Pharma Subsidiary Gains Drug Approval
PremiumCompany Announcements
Fosun Pharma Advances Cancer Treatment Trial
PremiumCompany Announcements
Shanghai Fosun Pharma Announces Board StructureOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
6.18% Mutual Funds
2.04% Other Institutional Investors
91.78% Public Companies and
Individual Investors
2196 FAQ
What was Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s price range in the past 12 months?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H lowest stock price was HK$11.32 and its highest was HK$21.10 in the past 12 months.
What is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s market cap?
Currently, no data Available
When is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s upcoming earnings report date?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s upcoming earnings report date is Aug 28, 2024 which is in 32 days.
How were Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s earnings last quarter?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H released its earnings results on Apr 29, 2024. The company reported HK$0.247 earnings per share for the quarter, missing the consensus estimate of HK$0.29 by -HK$0.043.
Is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H overvalued?
According to Wall Street analysts Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s price is currently Overvalued.
Does Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H pay dividends?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H pays a Annually dividend of HK$0.3 which represents an annual dividend yield of 3.49%. See more information on Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H dividends here
What is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s EPS estimate?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s EPS estimate is HK$0.3.
How many shares outstanding does Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H have?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H has 551,940,500 shares outstanding.
What happened to Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s price movement after its last earnings report?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H reported an EPS of HK$0.247 in its last earnings report, missing expectations of HK$0.29. Following the earnings report the stock price went up 0.977%.
Which hedge fund is a major shareholder of Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H?
Currently, no hedge funds are holding shares in HK:2196
---
Shanghai Fosun Pharmaceutical (Group) Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.33%
12-Months-Change
Fundamentals
Return on Equity
4.32%
Trailing 12-Months
Asset Growth
0.72%
Trailing 12-Months
Company Description
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H
Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.
---
2196 Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---